News

Novartis: Q2 Earnings Review - Solid Results Justify All-Time High Share Price
Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...
IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine.
International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...
InvestorsHub on MSN7h
Abbott’s Q2 revenue surpasses expectations despite share decline
The healthcare leader posted adjusted earnings per share of $1.26 for the quarter, slightly above the consensus estimate of ...
Novartis15h
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
Sales growth driven by continued strong performance from Kisqali (+64% cc), Entresto (+22% cc), Kesimpta (+33% cc), Scemblix (+79% cc), Leqvio (+61% cc) and Pluvicto (+30% cc) Core operating income ...
Kinder Morgan Reports Better-Than-Expected Q2 Results: Details
The Details: Kinder Morgan reported quarterly earnings of 28 cents per share, which beat the analyst consensus estimate of 27 ...
Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance
Johnson & Johnson beat Q2 estimates and raised its 2025 outlook, driven by strong cancer and MedTech sales despite Stelara ...
Notable healthcare headlines for the week: Trump’s tariff threat, Merck, UnitedHealth and Moderna in focus
Wall Street’s major averages ended slightly lower last week, after posting back-to-back record closes as market participants juggled Trump's tariff announcements against a healthy appetite for ...
SA Quant's top healthcare picks amid Q2 earnings season
The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of ...